Transforming growth factor-? differentially inhibits epithelial ovarian carcinoma cells from primary and metastatic isolates without up-regulation of p21WAF1
Open Access
- 15 April 1999
- Vol. 85 (8) , 1810-1815
- https://doi.org/10.1002/(sici)1097-0142(19990415)85:8<1810::aid-cncr22>3.0.co;2-e
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Cell Cycle and CancerJNCI Journal of the National Cancer Institute, 1995
- New Gynecologic Cancer StagingGynecologic Oncology, 1995
- Potential Role of WAF1/Cip1/p21 as a Mediator of TGF-β Cytoinhibitory EffectPublished by Elsevier ,1995
- p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest.Genes & Development, 1994
- Clonal Origin of Epithelial Ovarian Carcinoma: Analysis by Loss of Heterozygosity, p53 Mutation, and X-Chromosome InactivationJNCI Journal of the National Cancer Institute, 1992
- Receptors for the TGF-β familyCell, 1992
- A rapid and simple method for the purification of tumor cells from ascitic fluid of ovarian carcinomaGynecologic Oncology, 1992
- Regulation of growth of normal ovarian epithelial cells andovarian cancer cell lines by transforming growth factor-ßAmerican Journal of Obstetrics and Gynecology, 1992
- The Transforming Growth Factor-βsPublished by Springer Nature ,1990
- Unusual antiproliferative effects of transforming growth factors-β 1 andβ 2 against primary cells from human tumorsBiotherapy, 1989